Further investigation of ADAM9, AGAP2 and PSEN1 levels in human subjects with APP-related disorders could help in understanding Alzheimer’s disease and autism spectrum disorders. This evidence concerns the gene AGAP2 and early-onset autosomal dominant Alzheimer disease.